One potential reason leptin has not panned out as a therapy on its own is a phenomenon known as leptin resistance. Thats when the body becomes desensitized to the hormone at higher levels, causing a person to feel hungry and eat more even though they have sufficient body fat
In recent years, extensive literature has reported that a variety of signaling pathways and transcription factors are involved in the fat differentiation process of WAT, such as the NOS pathway, neuropeptide S [87] pathway, SIRT1 [88] pathway, STAT3 [89], bone morphogenetic protein 4 (BMP4) [90] pathway, etc
However, the inclusion of abnormal insulin metabolism in the brain as part of type 3 diabetes is a break from conventional wisdom and therefore has not yet been agreed upon in the academic community
By maintaining open communication with your medical team, you can navigate the complexities of GLP-1-related hair loss and work towards a solution that supports both your weight management and hair health goals
Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects
Mounjaro has been approved recently for both obesity and diabetes, with access initially limited to specialist clinics
